← SynDRA
LANIFIBRANOR
SynDRA canonical compound SYN0039273 — structure-anchored drug synonym record
| Clinical phase | Phase 2 |
|---|
| Primary target(s) | PPARA | PPARD | PPARG |
|---|
| Mechanism of action | PPAR receptor agonist |
|---|
All known targets
Mechanisms of action (all sources)
- PPARG AGONIST
- Peroxisome proliferator-activated receptor agonist
- PPARA AGONIST
- PPARD AGONIST
- PPAR receptor agonist
Cross-references
Synonyms
- IVA337
- IVA-337
- UNII-28Q8AG0PYL
- 28Q8AG0PYL
- CHEMBL4091374
- CPD1537
- 4-(1-(1,3-Benzothiazol-6-ylsulfonyl)-5-chloro-indol-2-yl)butanoic acid
- 1H-Indole-2-butanoic acid, 1-(6-benzothiazolylsulfonyl)-5-chloro-
- 4-[1-(1,3-benzothiazol-6-ylsulfonyl)-5-chloro-indol-2-yl]butanoic acid
- 4-[1-(1,3-benzothiazol-6-ylsulfonyl)-5-chloroindol-2-yl]butanoic acid
- Lanifbranor
- Libfranor
- Lanifbranor [INN]
- Lanifibranor(IVA-337)
- SCHEMBL3528615
- AMY16813
- EX-A1511
- BDBM50244350
- s8770
- DB14801
- SB18746
- AC-31451
- AK689102
- BS-17993
- HY-104049
- CS-0027586
- Q27896056
- 1-(6-Benzothiazolylsulfonyl)-5-chloro-1H-indole-2-butanoic Acid
- 5-Chloro-1-((6-benzothiazolyl)sulfonyl)-1H-indole-2-butanoic acid
- 4-(1-(benzo[d]thiazol-6-ylsulfonyl)-5-chloro-1H-indol-2-yl)butanoic acid
- BJB
- lanifibranorum
- RefChem:152253
- Lanifibranor?
- LANIFIBRANOR [INN]
- Lanifibranor (IVA-337)
- C19H15ClN2O4S2
- LANIFIBRANOR [WHO-DD]
- SCHEMBL29368039
Look up LANIFIBRANOR in the interactive SynDRA portal →